Publications by authors named "Michaela R Richardson"

Background: Incidence rates of pediatric cancers in the United States are typically reported in 5-year age groups, obscuring variation by single year of age. Additionally, racial and ethnic variation in incidence is typically presented in broad categories rather than by narrow age ranges.

Methods: The Surveillance, Epidemiology, and End Results (SEER) 18 data (2000-2017) were examined to calculate frequencies and age-adjusted incidence rates among individuals aged birth to 39 years.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates factors that impact early mortality in patients diagnosed with myelodysplastic syndromes (MDS), comparing those who die within a year to those who survive longer.
  • Researchers enrolled adults with new MDS diagnoses and utilized logistic regression to identify predictors of early death, considering various risk categories and treatment settings.
  • Findings reveal that abnormal cytogenetics, the presence of multiple cytogenetic abnormalities, treatment at community centers, and having multiple medical comorbidities significantly increase the odds of early mortality, emphasizing the importance of cytogenetic health in MDS management.
View Article and Find Full Text PDF

Studies have reported increased risks of pediatric acute lymphoblastic leukemia (ALL) among children born by cesarean delivery (CD). However, no previous study has examined the impact of CD on risk of infant leukemia specifically. In this study, 443 infants diagnosed with acute leukemia, including both ALL and acute myelogenous leukemia (AML), were identified at Children's Oncology Group institutions between January 1996 and December 2006; 324 controls frequency matched by year of birth were identified though random digit dialing and random selection from U.

View Article and Find Full Text PDF

Family history of lymphoid neoplasm (LN) is a strong and consistently observed Hodgkin lymphoma (HL) risk factor, although it has been only marginally examined in pediatric/adolescent patients. Here, healthy control children identified by random digit dialing were matched on sex, race/ethnicity and age to HL cases diagnosed at 0-14 years at Children's Oncology Group institutions in 1989-2003. Detailed histories were captured by structured telephone interviews with parents of 517 cases and 783 controls.

View Article and Find Full Text PDF